Hormonal Therapies

If the tumor has receptors for estrogen and progesterone (proteins present on the surface of some cancer cells), it is necessary to undergo a "hormonal" or anti-estrogen therapy. If the patient is in the fertile or premenopausal phase, the analogues of GNRH or hormones that block ovarian activity are added to these drugs. They are administered every month or every three months according to the intramuscular formulations. In addition to blocking ovarian activity, these drugs protect the ovaries to be able to reactivate once the therapy is finished and to be able to consider the recovery... Read More